Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II)
This is a randomized, open-label Phase II study evaluating the safety and efficacy of intravitreally administered ranibizumab 0.5mg in subjects with Proliferative Diabetic Retinopathy experiencing post- Panretinal Photocoagulation (PRP) macular edema.
100 Clinical Results associated with J. Michael Maloney, M.D., P.C.
0 Patents (Medical) associated with J. Michael Maloney, M.D., P.C.
100 Deals associated with J. Michael Maloney, M.D., P.C.
100 Translational Medicine associated with J. Michael Maloney, M.D., P.C.